This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignees: Mallinckrodt, Inc., Specgx LLC. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2026
Title: Exploring the Innovations of Inventor Dennis C. Aubuchon
Introduction
Dennis C. Aubuchon, an innovative inventor based in Arnold, Missouri, holds two significant patents that contribute to the field of pharmaceutical manufacturing. His work focuses on enhancing the purity of morphinan-6-one products, which has implications for various medicinal applications.
Latest Patents
The latest patents attributed to Dennis C. Aubuchon include a process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds. This invention details methods for achieving highly pure morphinan-6-one products by reducing the concentration of undesired impurities through treatment with sulfur-containing compounds. His continuous quest for innovation in this domain ensures that the pharmaceutical industry can produce safer and more effective medications.
Career Highlights
Dennis C. Aubuchon works at Mallinckrodt, Inc., an established name in the pharmaceutical sector, which underscores the importance of his contributions to the industry. Throughout his career, he has demonstrated a commitment to advancing processes that enhance the quality of pharmaceutical products.
Collaborations
In his pursuit of innovation, Dennis has collaborated with notable coworkers, including Henry J. Buehler and William E. Dummitt. These partnerships highlight the collaborative spirit within the research community, instrumental in fostering breakthroughs in pharmaceutical science.
Conclusion
In summary, Dennis C. Aubuchon is a noteworthy inventor whose patents focus on improving the methodology for producing high-purity morphinan-6-one products. His work, supported by his collaboration with esteemed colleagues at Mallinckrodt, Inc., continues to influence the pharmaceutical industry positively, paving the way for advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
